ModifiedPremera BluecrossPolicy N/A

Shoulder Arthroscopy in Adults — Coverage Criteria

Defines medical necessity, site-of-service guidance, documentation, and coding information for elective shoulder arthroscopy procedures in adults for Premera Blue Cross; applies to providers requesting coverage and decisions about appropriate outpatient sites.

Policy Summary

PayerPremera Bluecross

PolicyShoulder Arthroscopy in Adults — Coverage Criteria

Policy CodePolicy N/A

Change TypeMaterial updates and additions

Effective DateFeb 6, 2026

Next Review DateN/A

Key ActionObtain prior authorization with documentation of disabling shoulder pain, imaging confirmation, and required conservative therapy (typically ≥3 months and ≥6 weeks PT) before elective arthroscopic shoulder procedures.

SourceLink

POLICY UPDATE CHANGES

New policy approved October 14, 2025, effective for dates of service on or after February 6, 2026, following 90-day provider notification.

Site of Service Ambulatory Service Center (ASC) Select Surgical Procedures criteria added.

Conservative management requirements modified to require both a medication trial and failure as well as a trial and failure of physical measures where noted for each indication.

Policy criteria for diagnostic arthroscopy, debridement arthroscopy, and biceps tenodesis were removed.

Thermal capsulorrhaphy is considered not medically necessary.

3 monthsconservative management trial commonly required

6 weeksminimum physical therapy trial for many indications

ASA III+

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

anesthesia risk level cited for site selection

90 daysprovider notification period

Coverage Criteria for Shoulder Arthroscopy

Thermal capsulorrhaphy — Not Medically Necessary

Thermal capsulorrhaphy (e.g., ORA-50 electrothermal system, ArthroCare system, Vulcan electrothermal arthroscopy system, VAPR II electrosurgical system) is considered not medically necessary as a treatment for shoulder joint instability.

Evidence summary: comparative studies do not demonstrate efficacy; case series report high rates of unsatisfactory results and complications (potential for net harm).

Codes and Coding Guidance

Covered CPT CodesCPTCovered

29827	Rotator cuff repair
29807	SLAP tear repair
29825	Capsular release/adhesive capsulitis
29806	Capsulorrhaphy for shoulder instability and/or laxity
29824	Distal clavicular excision (Mumford procedure)
29819	Loose or foreign body removal
29826	Subacromial decompression/acromioplasty
29820	Synovectomy (partial)
29821	Synovectomy (complete)

Covered CPT CodesCPTCovered

23929	Unlisted procedure, shoulder.
29806	Arthroscopy, shoulder, surgical; capsulorrhaphy.
29807	Arthroscopy, shoulder, surgical; repair of SLAP lesion.
29819	Arthroscopy, shoulder, surgical; with removal of loose body or foreign body.
29820	Arthroscopy, shoulder, surgical; synovectomy, partial.
29821	Arthroscopy, shoulder, surgical; synovectomy, complete.
29824	Arthroscopy, shoulder, surgical; distal claviculectomy including distal articular surface (Mumford procedure).
29825	Arthroscopy, shoulder, surgical; with lysis and resection of adhesions, with or without manipulation.
29826	Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ligament release.
29827	Arthroscopy, shoulder, surgical; with rotator cuff repair.

1–10 of 11

1/2

Removed CPT CodesCPTNot Covered

29805	CPT code removed from policy
29822	CPT code removed from policy
29823	CPT code removed from policy
29828	CPT code removed from policy

Not Medically Necessary / ExperimentalmixedNot Covered

Thermal capsulorrhaphy (e.g., ORA-50, ArthroCare, Vulcan, VAPR II) — considered not medically necessary

Relevant surgical procedure CPT groups referenced in evidencemixed

CPT (example group)	arthroscopic subacromial decompression / acromioplasty (documented in evidence trials)
CPT (example group)	biceps tenodesis / tenotomy (comparative trials and meta-analyses)
CPT (example group)	rotator cuff repair (open/arthroscopic/mini-open) discussed in trials and guidelines
CPT (example group)	SLAP repair / labral repair (discussed in SLAP trials)
CPT (example group)	arthroscopic capsular release / manipulation under anesthesia (adhesive capsulitis trials)

MELD Score (ancillary threshold)

MELD Score threshold> 8

ContextListed as a liver risk factor that may necessitate hospital-based site-of-service rather than ASC

UseConsider in site-of-service prior authorization when advanced liver disease present

FEV1 for COPD (site-of-service threshold)

FEV1 threshold for COPD< 50%

ContextCited as pulmonary risk that may require hospital-based site-of-service review

UseConsider during site-of-service prior authorization for patients with COPD

FEV1 for asthma (site-of-service threshold)

FEV1 threshold for asthma< 80% despite treatment

ContextCited as poorly controlled asthma that may necessitate hospital-based site-of-service

UseConsider in site-of-service review and anesthesia planning

BMI threshold influencing site-of-service decisions

BMI threshold>= 50

ContextListed as morbid obesity criterion influencing site-of-service selection (may require hospital setting)

UseConsider when determining ASC versus hospital outpatient/inpatient site-of-service

Conservative management duration — documentation requirement

Conservative management documented duration3 months of failed non-operative care

Required elementsTrial of medications (NSAIDs or acetaminophen) and injections as appropriate

Imaging/documentationInclude imaging confirming pathology where specified (MRI/CT/x-ray)

Physical therapy duration

Physical therapy minimum duration>= 6 weeks

Allowed formatMay include PT-directed home exercise

UseRequired trial length for many arthroscopic shoulder indications prior to authorization

Conservative management duration (>= 3 months)

Conservative management minimum duration>= 3 months

ComponentsMedication trial (NSAIDs/acetaminophen) ± appropriate corticosteroid injection and PT ≥6 weeks

ExceptionsNot required for acute traumatic complete tears with debilitating loss of function

Rotator cuff tear size threshold (<= 3 cm) referenced in evidence

Rotator cuff tear size threshold≤ 3 cm (anterior-posterior full‑thickness)

Evidence contextThreshold used in 15-year RCT showing superiority of primary tendon repair vs physiotherapy

DocumentationTear size should be documented (imaging) when considering rotator cuff repair

Prior Authorization, Documentation, and Denial Risks

Prior Authorization

Prior Authorization for Listed Shoulder Arthroscopy CPT Codes

Prior Authorization Required: Prior authorization is required for listed shoulder arthroscopy CPT codes. Submit clinical documentation that demonstrates the applicable medical necessity criteria for the specific shoulder procedure (see applicable indication criteria) prior to services.

Prior auth required for CPT codes listed above.
Include indication-specific clinical documentation (history, exam, imaging, prior conservative therapy).

Note

Prior Authorization Timing and Effective Date

Prior authorization should be obtained before the date of service. This policy is effective for dates of service on or after 2026-02-06; obtain authorization for elective shoulder arthroscopy scheduled on or after that date. Providers will have been given a 90-day notification prior to the effective date; verify member benefits and any plan-specific prior authorization submission processes.

Obtain prior authorization prior to scheduling elective procedures.

Background and Evidence Summary

Shoulder arthroscopy is a minimally invasive operative approach used to diagnose and treat intra-articular shoulder disorders such as rotator cuff tears, labral/SLAP lesions, adhesive capsulitis, instability, impingement, and intra-articular loose bodies. Compared with open surgery, arthroscopy generally allows smaller incisions and may reduce postoperative pain and recovery time; this policy defines specific indications, required documentation, conservative-therapy prerequisites, and site-of-service considerations for elective shoulder arthroscopy in adults.

Clinical evidence includes randomized controlled trials and systematic reviews showing that many shoulder surgeries have limited short-term advantages over structured nonoperative care. For degenerative rotator cuff tears, multiple RCTs and meta-analyses found little or no benefit at one year, though long-term follow-up of selected small-to-medium tears showed superiority of repair. Placebo-controlled trials of subacromial decompression found no clinically important benefit over sham or exercise, and RCTs of SLAP II repair in middle-aged adults did not demonstrate benefit compared with sham. These data support conservative management and careful patient selection before operative intervention.

Short-term evidence from randomized trials and Cochrane/systematic reviews indicates that, for many patients with degenerative rotator cuff disease or subacromial impingement, structured nonoperative treatment (exercise programs, NSAIDs, and selective corticosteroid injections) provides similar outcomes to surgery through the first year. Therefore, the policy requires documentation of failed conservative management (commonly 3 months including at least 6 weeks of physical therapy where specified) before authorization of many arthroscopic procedures.

Rationale for the not medically necessary designation for thermal capsulorrhaphy: the literature does not demonstrate efficacy for treating shoulder instability, comparative studies are unsupportive of benefit, and case series report high complication and failure rates. Given the absence of clinical benefit and potential for harm, the procedure is excluded from coverage and specifically listed as not medically necessary in this policy.

Definitions and Clinical Terms

Subacromial impingement / acromion types (Type II/III)

Relevant acromion typesType II (curved) and Type III (hooked)

Clinical meaningShapes that reduce subacromial space and are consistent with subacromial impingement

UseImaging finding supportive of subacromial decompression/acromioplasty criteria

ASA classification III or higher (used in site-of-service guidance)

ASA classificationASA III or higher

ContextAnesthesia risk factor that may necessitate hospital-based site-of-service review rather than ASC

Use

Policy Revisions and Effective Dates

2025-10-14policy_addition

New shoulder arthroscopy policy approved and added to Surgical section; thermal capsulorrhaphy designated not medically necessary and ASC site-of-service criteria added; 90-day provider notification provided before effective date.

2026-02-06effective_date

Policy became effective for dates of service on or after February 6, 2026; providers to follow Premera prior authorization processes for shoulder arthroscopy.

2026-03-10interim_revision

Policy Summary

PayerPremera Bluecross

PolicyShoulder Arthroscopy in Adults — Coverage Criteria

Policy CodePolicy N/A

Change TypeMaterial updates and additions

Effective DateFeb 6, 2026

Next Review DateN/A

SourceLink

On This Page

Verify member benefits for coverage limitations, frequency, and site-of-service rules.

Step Therapy

Conservative Therapy Required Before Surgery

Conservative therapy is required prior to arthroscopic shoulder surgery where noted in the indication-specific criteria. Documentation must show failure of at least three months of non-operative care (medication trial AND physical measures) unless exception criteria apply (e.g., acute traumatic complete tear with debilitating loss of function).

Medication trial: documented trial and failure of one or more of NSAIDs or acetaminophen and/or appropriate corticosteroid injection (subacromial or intra-articular) as indicated.
Physical measures: documented trial and failure of physical therapy for at least 6 weeks (may include PT-directed home exercise).
Exceptions: acute traumatic complete tears with debilitating pain and loss of function may not require prior conservative therapy per indication-specific criteria.

Consider in site-of-service prior authorization and anesthesia planning

Subacromial impingement imaging (x-ray/MRI findings)

Imaging supportive of subacromial impingementPlain x-rays or MRI/CT demonstrating findings consistent with impingement (e.g., Type II or III acromion)

UseRequired for subacromial decompression criteria alongside positive impingement test and failed conservative care

ExamplesType II curved or Type III hooked acromion on imaging

Instability imaging findings (Bankart, Hill-Sachs, capsular lesions)

Instability imaging findingsMRI demonstrating labral lesion consistent with instability (e.g., Bankart), Hill‑Sachs lesion, capsular tear, or capsular redundancy with multidirectional instability

UseRequired to support capsulorrhaphy for instability criteria

ExamplesLabral Bankart lesion, Hill‑Sachs defect, capsular thickening/edema

Acromioplasty definition

DefinitionSurgical removal of part of the acromion to relieve rotator cuff impingement by increasing subacromial space

Synonym/ProcedureAlso referred to as acromioplasty or subacromial decompression

UseConsidered as an add-on procedure only with other medically necessary primary shoulder procedures per policy

Biceps tenodesis definition

DefinitionSurgical reattachment of the biceps tendon to the humerus after detachment or damage at the shoulder

ApproachMay be performed open or arthroscopically

UseDocumented as an option for biceps pathology; compared with tenotomy in evidence summaries

Cofield / Ellman classifications (tear size/grade systems)

Cofield classification (full‑thickness tears)Small <1 cm; Medium 1–3 cm; Large 3–5 cm; Massive >5 cm

Ellman classification (partial‑thickness)Grade 1 <3 mm; Grade 2 3–6 mm; Grade 3 >6 mm

UseUsed to describe tear size/depth for eligibility and documentation (e.g., ≤3 cm considered small‑to‑medium)

SLAP II lesion definition and trial context

SLAP II lesion definitionSuperior labrum anterior‑posterior (SLAP) tear type II

Evidence contextDouble‑blind RCT in middle‑aged adults (mean age 40) showed no benefit of repair or tenodesis over sham at 24 months

ImplicationConsider alternatives (biceps tenotomy/tenodesis or debridement) especially in older patients or when concomitant rotator cuff tear present

Small-to-medium rotator cuff tear definition (<=3 cm) per RCT

Definition used in RCTsSmall‑to‑medium full‑thickness rotator cuff tear defined as ≤3 cm anterior‑posterior

Evidence15‑year randomized trial (Moosmayer) used this threshold and found long‑term benefit for tendon repair versus physiotherapy

DocumentationTear size should be recorded on imaging when applying trial evidence to clinical decisions

Key evidence base (RCTs, systematic reviews cited)

Types of evidence citedRandomized controlled trials, systematic reviews, and meta‑analyses

Key topics coveredRotator cuff repair RCTs (including 15‑year follow‑up), SLAP sham‑controlled RCT, subacromial decompression placebo‑controlled trials, and systematic reviews of biceps procedures and adhesive capsulitis

UseEvidence base informs coverage stance and documentation requirements (e.g., tear size, failed conservative care)

Interim review updated conservative management language to require both a medication trial and failure and a trial and failure of physical measures for applicable indications; criteria and CPT code removals aligned with these changes.